BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8172827)

  • 41. High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with Hodgkin's lymphoma.
    Salgami EV; Efstathiou SP; Vlachakis V; Sekara EV; Syrigos KN; Roussou PP
    Haematologia (Budap); 2002; 32(4):377-87. PubMed ID: 12803112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.
    Foss HD; Herbst H; Gottstein S; Demel G; Araujó I; Stein H
    Am J Pathol; 1996 Apr; 148(4):1229-36. PubMed ID: 8644863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
    Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
    Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
    Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
    Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease.
    Nadali G; Vinante F; Rigo A; Tecchio C; Morosato L; Zanolin E; Perona G; Chilosi M; Pizzolo G
    Int J Clin Lab Res; 1995; 25(2):84-7. PubMed ID: 7663010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value.
    Uskudar Teke H; Gulbas Z; Bal C
    J BUON; 2014; 19(1):191-7. PubMed ID: 24659663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.
    Krueger GR; Guenther A; Knuefermann R; Kluppelberg U; Luka J; Pearson GR; Ablashi DV; Juecker M; Tesch H
    In Vivo; 1994; 8(4):501-16. PubMed ID: 7893977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease.
    Pui CH; Ip SH; Thompson E; Wilimas J; Brown M; Dodge RK; de Hoyos RA; Berard CW; Crist WM
    Leukemia; 1989 Jul; 3(7):481-4. PubMed ID: 2786597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.
    Foss HD; Hummel M; Gottstein S; Ziemann K; Falini B; Herbst H; Stein H
    Am J Pathol; 1995 Jan; 146(1):33-9. PubMed ID: 7856736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.
    Shearer WT; Reuben JM; Mullington JM; Price NJ; Lee BN; Smith EO; Szuba MP; Van Dongen HP; Dinges DF
    J Allergy Clin Immunol; 2001 Jan; 107(1):165-70. PubMed ID: 11150007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
    Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
    Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
    Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
    J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma.
    Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Rassidakis GZ; Doussis-Anagnostopoulou IA; Hatzioannou M; Vaiopoulos G; Kittas C; Sarris AH; Pizzolo G; Pangalis GA
    Haematologica; 2001 Mar; 86(3):274-81. PubMed ID: 11255274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct expression levels of cytokines and soluble cytokine receptors in seminal plasma of fertile and infertile men.
    Huleihel M; Lunenfeld E; Levy A; Potashnik G; Glezerman M
    Fertil Steril; 1996 Jul; 66(1):135-9. PubMed ID: 8752625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
    Kakumu S; Okumura A; Ishikawa T; Yano M; Enomoto A; Nishimura H; Yoshioka K; Yoshika Y
    Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma.
    Dlouhy I; Filella X; Rovira J; Magnano L; Rivas-Delgado A; Baumann T; Martínez-Trillos A; Balagué O; Martínez A; González-Farre B; Karube K; Gine E; Delgado J; Campo E; López-Guillermo A
    Leuk Res; 2017 Aug; 59():20-25. PubMed ID: 28544905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
    Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
    Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of eosinophils in the pathobiology of Hodgkin's disease.
    Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Perin V; Todesco M; De Iuliis A; Improta S; Sacco C; Gattei V; Gruss HJ; Carbone A
    Ann Oncol; 1997; 8 Suppl 2():89-96. PubMed ID: 9209649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.